Thompson Coburn partner Michael Rosenblum authored articles in the Daily Journal and Law360 on recent landmark developments for the cannabis industry including the Department of Health and Human Services (HHS) recommendation to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA) and the progress of the Secure and Fair Enforcement Regulation (SAFER) Banking Act in Congress.
For Daily Journal, Michael wrote, “HHS’ recommendation was soon followed by another historic development, as the Senate Banking Committee approved the Secure and Fair Enforcement Regulation (SAFER) Banking Act in September. The event marked the first time a stand-alone cannabis bill received a ‘yes’ vote in the Senate, signaling a potential shift in legislative perspectives.” He noted that while both developments are watershed moments for the industry in showing the extent to which federal viewpoints have changed, they have uncertain fates.
In the Law360 article, Michael describes the journey the SAFER Banking Act has been through so far and the potential setbacks it may still face. “For industry participants and advocates, federal progress regarding cannabis legislation has been painfully slow and the passage of a federal cannabis banking act is alluring. But the creation of a new legal industry is a marathon, not a sprint in practice.” Full federal legalization, he noted, is “the only outcome that can adequately resolve the financial needs of those in the industry, sparking growth and stability, which will benefit consumers, boost tax revenues, and improve public safety and oversight.”
Click here to read the full Daily Journal article (subscription required). Click here to read the full Law360 article.
NOTICE.
Although we would like to hear from you, we cannot represent you until we know that
doing so will not create a conflict of interest. Also, we cannot treat unsolicited
information as confidential. Accordingly, please do not send us any information
about any matter that may involve you until you receive a written statement from
us that we represent you (an ‘engagement letter’).
By clicking the ‘ACCEPT’ button, you agree that we may review any information you transmit to us. You recognize that our review of your information, even if you submitted it in a good faith effort to retain us, and, further, even if you consider it confidential, does not preclude us from representing another client directly adverse to you, even in a matter where that information could and will be used against you. Please click the ‘ACCEPT’ button if you understand and accept the foregoing statement and wish to proceed.